Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group..

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646.

2.

Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.

Allin KH, Nordestgaard BG.

Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155-70. doi: 10.3109/10408363.2011.599831. Review.

PMID:
22035340
3.

C-reactive protein, fibrinogen, and cardiovascular disease prediction.

Emerging Risk Factors Collaboration., Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J.

N Engl J Med. 2012 Oct 4;367(14):1310-20. doi: 10.1056/NEJMoa1107477.

4.

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J.

Clin Infect Dis. 2004 Jul 15;39(2):206-17. Review. Erratum in: Clin Infect Dis. 2005 May 1;40(9):1386-8.

6.

Vitamin C treatment reduces elevated C-reactive protein.

Block G, Jensen CD, Dalvi TB, Norkus EP, Hudes M, Crawford PB, Holland N, Fung EB, Schumacher L, Harmatz P.

Free Radic Biol Med. 2009 Jan 1;46(1):70-7. doi: 10.1016/j.freeradbiomed.2008.09.030.

7.

Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT.

Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura S, Kikuchi M, Okuda S, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y.

Bone Marrow Transplant. 2013 May;48(5):698-702. doi: 10.1038/bmt.2012.193.

PMID:
23042494
8.

Function of C-reactive protein.

Du Clos TW.

Ann Med. 2000 May;32(4):274-8. Review.

PMID:
10852144
9.

Characteristics of febrile patients with normal white blood cell counts and high C-reactive protein levels in an emergency department.

Liu KT, Lin TJ, Chan HM.

Kaohsiung J Med Sci. 2008 May;24(5):248-53. doi: 10.1016/S1607-551X(08)70149-9.

10.

Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance.

Costenbader KH, Chibnik LB, Schur PH.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):746-9.

PMID:
18078625
11.

Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice.

Colombet I, Pouchot J, Kronz V, Hanras X, Capron L, Durieux P, Wyplosz B.

Am J Med. 2010 Sep;123(9):863.e7-13. doi: 10.1016/j.amjmed.2010.04.021.

PMID:
20800157
12.

An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks.

Hofer N, Zacharias E, Müller W, Resch B.

Neonatology. 2012;102(1):25-36. doi: 10.1159/000336629. Review.

13.

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Emerging Risk Factors Collaboration., Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J.

Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7.

14.

Comparison of procalcitonin and C-reactive protein as markers of sepsis.

Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A.

Crit Care Med. 2003 Jun;31(6):1737-41.

PMID:
12794413
16.

C-reactive protein in normal pregnancy.

Watts DH, Krohn MA, Wener MH, Eschenbach DA.

Obstet Gynecol. 1991 Feb;77(2):176-80.

PMID:
1988876
17.

C-reactive protein in viral and bacterial respiratory infection in children.

Korppi M, Kröger L.

Scand J Infect Dis. 1993;25(2):207-13.

PMID:
8511515
18.

Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.

Tayyebi-Khosroshahi H, Houshyar J, Dehgan-Hesari R, Alikhah H, Vatankhah AM, Safaeian AR, Zonouz NR.

Saudi J Kidney Dis Transpl. 2012 May;23(3):500-6.

19.
20.

Serial serum C-reactive protein levels in the diagnosis of neonatal infection.

Benitz WE, Han MY, Madan A, Ramachandra P.

Pediatrics. 1998 Oct;102(4):E41.

PMID:
9755278
Items per page

Supplemental Content

Support Center